SUMMARY
IntroductIon
According to the ESC guidelines for diagnosis and treatment PH published in 2009 (Dana pointe 2008) the pulmonary hypertension (PH) is a haemodynamic and pathophysiologicaal condition defined as increase in mean Pulmonary Artery Pressure (PAP) ≥ 25mmHg at rest as aasessed by right heart catheterization (RHC). According to the ESC guidelines for diagnosis and treatment PH (2009) the clinical classification of pulmonary hypertension (Dana pointe 2008) includes PH associated with congenital heart disease and pulmonary hypertension due to left heart disease is classified as Post-Capilary PH and defined by by a mean PAP ≥ 25mmHg, PWP > 15mmmHg, cardiac output (CO) is normal or reduced and passive TPG ≤ 12mmHg, active TPG > 12mmHg APAH. The signs and symptoms of the pulmonary hypertension are often unspecific and inconspicuous; therefore it is hard to distinguish whether they pertain to an underlying cardiac or extra cardiac disease. An exact evaluation of whether the pulmonary hypertension exists can be achieved by echocardiography, as a non-invasive examination method, and by right heart catheterization as an invasive diagnostic method (1, 2, 3).
In the majority of patients with various cardiac diseases, either as part of the basic characteristics of the illness or as a complication of untreated heart disease can lead to the pulmonary hypertension, which signs or symptoms are often subtle and nonspecific. Regardless of the etiology of untreated pulmonary hypertension it can lead to right heart failure. The diagnosis of pulmonary hypertension is quite difficult because it requires a precise evaluation, registration and determination of hemodynamic parameters to be defined. Exact evaluation of the existence of pulmonary hypertension and its level can be achieved by echocardiography as a noninvasive method of examination and right heart catheterization and pulmonary artery as invasive diagnostic method (4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18) . 
research oBJectIVes
The objective of this study is to determine, by investigating haemodynamic parameters of the pulmonary hypertension in congenital and left heart diseases, the linkage and diagnostic value of echocardiography in detecting the pulmonary hypertension in heart diseases and assessing its degree. To evaluate whether the haemodynamic parameters of pulmonary hypertension in heart disease obtained by echocardiography (TTE and TEE) as a noninvasive diagnostic method is in correlation with the hemodynamic parameters of right heart catheterization as the invasive method. Also to determine whether echocardiography (TTE and TEE) can be considered a reliable diagnostic modality in detecting and assessing pulmonary hypertension in patients with heart diseases ( Figure 1, Figure 2 ).
PatIents and Methods
The research covered 56 adult subjects of both genders, who were subjected to echocardiography as part of the clinical cardiological examination. The patients were examined on an ultrasound machine ATL HDI-5000, equipped with a cardiologic probe for adults 2.25 MHz and a multi-plan transoesophageal probe ATL MPT7-4 TEE. Using Doppler echocardiography can evaluate the following hemodynamic parameters that are relevant in the diagnosis of pulmonary hypertension: a) systolic pressure in the pulmonary artery (SPAP), b) systolic pressure in right ventricle (RVSP), c) the mean pulmonary artery pressure (MPAP), d) diastolic pulmonary artery pressure (DPAP), e) Index pulmonary f low velocity Act, RVET, PEP, AcT/RVET, PEP/AcT PEP/RVET.
The patients, for whom invasive cardiologic diagnostic methods were indicated following evaluation by echocardiography, were subjected to heart cardiac catheterization.
The patients for whom invasive cardiac diagnostics was indicated following the Echocardiographic evaluation and estimation of pulmonary hypertension were subjected to right heart catheterization. RHC was performed in all patients and diagnosis of pulmonary hypertension was established by measuring mean PAP ≥ 25mmHg at rest, also left heart catheterization was performed in order to define the underlying heart disease.
The echocardiographic Doppler and haemodynamic parameters, obtained for each method applied, have been statistically processed.
results
Among all the cardiac patients referred for echocardiographic evaluation for pulmonary hypertension 56 patients entered the study. Baseline characteristics of the population are depicted in Table 1 . Hemodynamic behavior of our pa- Table 2 . Right heart catheterization confirmed normal or borderline finding in 10 patients (18%), moderate pulmonary hypertension in 31 patients (55%) and severe PH in 15 patients (27%).
dIscussIon
Pulmonary hypertension (PH) is an important hemodynamic parameter that monitors a wide range of cardiac and extra cardiac diseases, which is crucial in determining the symptomatology, clinical features and treatment of these diseases. Early identification of patients with pulmonary hypertension is a very significant and important impact on morbidity and mortality (19, 20, 21, 22, 23, 24, 25) .
The study results indicate significant correlation between the haemodynamic parameters obtained by Doppler echocardiographic methods for PAP estimation as a non-invasive diagnostic method compared to invasive diagnostics i.e. right heart catheterization, which is the gold standard for the detection and evaluation of PH. Our results are similar to that reported on previous published studies shown in Table 3 (16, 17, 18, 19, 20, 21, 22 
conclusIon
Significant correlation has been found between the haemodynamic parameters obtained by Doppler noninvasive echocardiographic estimation of pulmonary hypertension and those obtained by invasive diagnostic methods i.e. right heart catheterization.
The results of our own study show a high degree of precision in applications of the Mahan equation in assessment of MPAP, Berger equation for the assessment of SPAP and modified Bernoulli equation to evaluation of RVSP.
Based on the study results it can be noted that echocardiography with all its modalities can be considered a reliable diagnostic tool in detecting and assessing the degree of pulmonary hypertension in heart disease. 
